Sophos Group plc is a security software and hardware company. Sophos develops products for communication endpoint, encryption, network security, email security and mobile security as well as unified threat management. Sophos is focused on providing security software to organizations, businesses, and individual users. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
Admission to trading on the London Stock Exchange 1 July 2015
LSE: SOPH

28 Jul Peel Hunt 360.00 Buy

29 Jul JP Morgan... 320.00 Overweight

15 Aug Deutsche Bank Buy 247.80 290.00 290.00 Reiterates

6 Sep Deutsche Bank 290.00 Buy

Litigation Ruling
RNS
RNS Number : 5429K
Sophos Group Plc
22 September 2016
 
Sophos Group plc
Litigation Ruling
 
 
London, 22 September 2016. Sophos Group plc ("Sophos" or the "Company") announces that the jury in the lawsuit brought by Finjan, Inc (Finjan) asserting certain patent claims against Sophos has found that the Company infringed on five of Finjan's patents, and has awarded Finjan a one-time damages payment of $15 million. This verdict represents the next step in an ongoing legal process and Sophos is considering all options including an appeal of the verdict.
 
Forward-looking Statements
Certain statements in this announcement constitute "forward-looking statements". These forward-looking statements involve risks, uncertainties and other factors that may cause the Group's actual results, performance or achievements, or industry results, to be materially different from those projected in the forward-looking statements.  These factors include: general economic and business conditions; changes in technology; timing or delay in signing, commencement, implementation and performance or programmes, or the delivery of products or services under them; structural change in the security industry; relationships with customers; competition; and ability to attract personnel.  You are cautioned not to rely on these forward-looking statements, which speak only as of the date of this announcement.  The Group undertakes no obligation to update or revise any forward-looking statement to reflect any change in expectations or any change in events, conditions or circumstances.
 

Sustained momentum in Q3

13:30 13/02/2017
Director Deals - Sophos Group Plc (SOPH)
Nick Bray, Financial Director, sold 46,209 shares in the company on the 10th February 2017 at a price of 281.65p. The Director now holds 1,315,320 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
13:25 13/02/2017
Director Deals - Sophos Group Plc (SOPH)
Kris Hagerman, Chief Executive Officer, sold 112,853 shares in the company on the 10th February 2017 at a price of 281.65p. The Director now holds 1,897,289 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com

Trading Update and Notice of Final Results
RNS
RNS Number : 4486B
Sophos Group Plc
04 April 2017
 
This announcement contains inside information within the purposes of article 7 of the EU Market Abuse Regulation 596/2014
Sophos Group plc
Trading Update and Notice of Final Results
Oxford, 4 April 2017.  Following a very strong end to the fourth quarter, Sophos Group plc (the "Group" / LSE: SOPH), a leading provider of cloud-enabled enduser and network security solutions, is pleased to provide a trading update in advance of announcing its final results for the year ended 31 March 2017.
The Group expects to report fourth quarter constant currency billings growth of approximately 27%, excluding any benefit from the recently announced acquisition of Invincea.  Full year constant currency billings growth is expected to be approximately 20%.  Reported billings, allowing for the currency headwind, are expected to grow approximately 18% to $630 million from $535 million in the year-ended 31 March 2016, ahead of the consensus range of $610 million to $617 million.  Consequently, Cash EBITDA and unlevered free cash flow are also expected to be ahead of the consensus range.
Notice of Results
Sophos will be announcing its final results for the year-ended 31 March 2017 on 17 May 2017.

5 Apr
Deutsche Bank
N/A
Buy
5 Apr
Citigroup
380.00
Buy

Final results due on Wednesday.

Even after the very bullish update on 4th April there could be scope for further upgrades after the worldwide cyber attack yesterday.

LedZep4 love it , first Zep album i heard and it blew my mind a very underrated band , listened to 3 and 1 the other day , stonking .

Victim,

LZ4 was indeed an extraordinary album. I was privileged enough to see them at Knebworth in 1979 (crowd of approximately 120,000) and also see Page & Plant at Shepherds Bush Empire in 1995 (approx. 2000 people) - tickets for the latter obtained courtesy of a tip off given by Ronnie Wood to my friend who was doing some electrical work at his house !!!

Happy days.

Anyway I think this could be a good week for Sophos.

;o)

Good call here LedZep4. In long on the spreads this morn for a quick punt @ 348.88p stop to lock in profit @ 358.88.

Stairway To Heaven classic :0)

08:30 15/05/2017
Broker Forecast - Deutsche Bank issues a broker note on Sophos Group Plc
Deutsche Bank today reaffirms its buy investment rating on Sophos Group Plc (LON:SOPH) and raised its price target to 350p (from 290p). Story provided by StockMarketWire.com

Final results

Business highlights
·      FY17 reported billings grew 18.2% to $632.1 million, or by 19.9% at constant currency, with strong momentum across all regions and products, in new business and renewals
·      Cash flow growth exceptionally strong, with unlevered free cash flow almost tripling to $133.4 million
·      Very strong performance from Sophos Central, growing 220% to $87.7 million from $27.4 million in the prior year; now representing 17.1% of subscription billings (FY16: 6.5%)
·      Enduser security increased by 24.4% to $298.5 million and network security grew by 17.8% to $319.1 million at constant currency, reflecting continued market share gains
·      Operating loss increased over prior-year, primarily as a consequence of cost increases associated with the strong growth in billings, whilst the majority of revenue is deferred and recognised over time
·      Deferred revenue grew 16.5%, growing $82.3 million to $581.0 million, increasing visibility of future revenue growth
·      Cash EBITDA margin increase by 110 basis points to 23.7%
·      Net renewal rate (including cross-sell and upsell) increased to 106% (FY16: 102%) with UTM/endpoint cross-sell at 9.6% (FY16: 7.4%)
·      Launch in September of Intercept X, a next-generation endpoint protection application, featuring signature-less anti-exploit and anti-ransomware capabilities, already with more than 8,000 customers
·      Integration of Invincea's machine learning technology progressing well, with new endpoint protection solution expected to be available in Sophos Central in 2017
·      Final dividend of 3.3 US Cents per share, an increase of 200%; total dividend for the year of 4.6 US Cents, an increase of 156% over the prior year

Well positioned in the market, with recent attacks.

The Co founder, Dr. Peter Lammer was in the year below me at School!

Will he give you a job in the company. lol

:-)